PillCam colon capsule endoscopy: a prospective, randomized trial comparing two regimens of preparation
CCE represents a new diagnostic, endoscopic technology for colonic exploration. NaP has been recently related to major side effects. Adequate preparation was achieved in 42.5% of the cases. The exclusion of NaP booster resulted in a clinically meaningful reduction of the capsule excretion rate that was only partially compensated by the PEG booster.

Related Post